We have seen 32 patients with ''apraxia of lid opening'' (ALO) in the
following clinical settings: as an isolated condition (3 patients), id
iopathic blepharospasm (BSP, 20 patients, including 4 familial cases),
progressive supranuclear palsy (PSP, 7 patients), and dystonic parkin
sonian syndrome (2 patients). Twenty-nine patients treated with botuli
num toxin into the orbicularis oculi muscle were rated before and afte
r treatment and 83% of the patients improved on a clinical scale. Best
results were obtained with injections directed toward the junction of
the preseptal and pretarsal parts of the palpebral orbicularis oculi.
Several patients also improved on anticholinergic drugs. Besides medi
cal treatment, lid crutches, in conjunction with botulinum toxin injec
tions, were useful in some patients. ALO is not a true apraxia; it con
stitutes an eyelid dystonia as shown by its clinical and electrophysio
logical features as well as pharmacological reactions and is encounter
ed in a clinical spectrum ranging from an isolated form to predominant
BSP. It was an important cause of treatment failures in botulinum tox
in-treated BSP but by modifying our injection strategy and by adding a
nticholinergic drugs and also lid crutches, we obtained a good functio
nal benefit.